NR2E3 antibody
Principal name
NR2E3 antibody
Alternative names for NR2E3 antibody
PNR, RNR, Photoreceptor-specific nuclear receptor, Retina-specific nuclear receptor, Nuclear receptor subfamily 2 group E member 3
SwissProt ID
Q9Y5X4 (Human)
Gene ID
10002 (NR2E3)
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Paraffin Sections (P)
Background of NR2E3 antibody
NR2E3 is part of a large family of nuclear receptor transcription factors involved in signaling pathways. Nuclear receptors have been shown to regulate pathways involved in embryonic development, as well as in maintenance of proper cell function in adults. NR2E3 is a retinal nuclear receptor that is a ligand-dependent transcription factor. Defects in this gene are a cause of enhanced S cone syndrome.This protein is part of a large family of nuclear receptor transcription factors involved in signaling pathways. Nuclear receptors have been shown to regulate pathways involved in embryonic development, as well as in maintenance of proper cell function in adults. Members of this family are characterized by discrete domains that function in DNA and ligand binding. This gene encodes a retinal nuclear receptor that is a ligand-dependent transcription factor. Defects in this gene are a cause of enhanced S cone syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified.
General readings
Hayashi,T., Ophthalmology 112 (12), 2115 (2005)
Western Blot analysis of NR2E3 expression in transfected 293T cell line by NR2E3 monoclonal antibody (M01), clone 2A12.Lane 1: NR2E3 transfected lysate(44.7 KDa).Lane 2: Non-transfected lysate.
Detection limit for recombinant GST tagged NR2E3 is approximately 0.3ng/ml as a capture antibody.
Human HepG2; WB Suggested Anti-NR2E3 Antibody Titration: 1.25ug/ml. Positive Control: HepG2 cell lysate; NR2E3 antibody - N-terminal region (ARP39069_T100) in Human HepG2 cells using Western Blot
Western Blot analysis of NR2E3 expression in transfected 293T cell line (H00010002-T01) by NR2E3 MaxPab polyclonal antibody.Lane 1: NR2E3 transfected lysate(45.1 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of NR2E3 expression in transfected 293T cell line (H00010002-T02) by NR2E3 MaxPab polyclonal antibody.Lane 1: NR2E3 transfected lysate(44.70 KDa).Lane 2: Non-transfected lysate.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR2E3 (RC220677, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR2E3.
Anti-NR2E3 antibody IHC of human retina. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
Anti-NR2E3 antibody IHC of human retina. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
Host: Rabbit; Target Name: NR2E3; Sample Tissue: Fetal Heart lysates; Antibody Dilution: 1.0ug/ml
WB Suggested Anti-NR2E3 Antibody Titration: 1.25 ug/ml; Positive Control: HepG2 cell lysate
Host: Rabbit; Target Name: NR2E3; Sample Tissue: OVCAR-3 Whole cell lysates; Antibody Dilution: 1.0 ug/ml
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA317090 | NR2E3 antibody |
||||||
| NR2E3 / PNR Rabbit Polyclonal (N-Terminus) Antibody | |||||||
 |
Rabbit | Aff - Purified | Hu | P |
50 µg /
€425.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA317091 | NR2E3 antibody |
||||||
| NR2E3 / PNR Rabbit Polyclonal (Ligand-binding Domain) Antibody | |||||||
|
Rabbit | Aff - Purified | Hu | P |
50 µg /
€425.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA806203 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI3D4 (formerly 3D4) | |||||||
 |
Mouse | IgG1 | OTI3D4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806217 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI2F6 (formerly 2F6) | |||||||
 |
Mouse | IgG1 | OTI2F6 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806218 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI3G3 (formerly 3G3) | |||||||
 |
Mouse | IgG1 | OTI3G3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806219 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI2G3 (formerly 2G3) | |||||||
 |
Mouse | IgG1 | OTI2G3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806222 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI3D9 (formerly 3D9) | |||||||
 |
Mouse | IgG1 | OTI3D9 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806269 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI1D3 (formerly 1D3) | |||||||
 |
Mouse | IgG1 | OTI1D3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806271 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI2H9 (formerly 2H9) | |||||||
 |
Mouse | IgG1 | OTI2H9 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806272 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI4H7 (formerly 4H7) | |||||||
 |
Mouse | IgG1 | OTI4H7 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806274 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI1F4 (formerly 1F4) | |||||||
 |
Mouse | IgG1 | OTI1F4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA806275 | NR2E3 antibody |
||||||
| NR2E3 mouse monoclonal antibody, clone OTI10C4 (formerly 10C4) | |||||||
 |
Mouse | IgG1 | OTI10C4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP315425 | NR2E3 (transcript variant 2) |
||||
| Recombinant protein of human nuclear receptor subfamily 2, group E, member 3 (NR2E3), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP320677 | NR2E3 (transcript variant 1) |
||||
| Recombinant protein of human nuclear receptor subfamily 2, group E, member 3 (NR2E3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY402296 | NR2E3 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |